オリゴヌクレオチド合成市場は2023年から2028年に33億7,404万米ドル、予測期間中のCAGRは13.54％で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、RNAベースの治療薬へのシフトの高まり、治療・診断ツールとしてのオリゴヌクレオチドの使用の増加、オリゴヌクレオチド合成における技術革新が牽引しています。
本調査では、オリゴヌクレオチド合成におけるAIと自動化の統合が、今後数年間のオリゴヌクレオチド合成市場成長を促進する主要な理由の1つであると指摘しています。また、オリゴヌクレオチド合成の調査と資金調達の増加、低コストでハイスループットなオリゴヌクレオチド合成の需要増が市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global oligonucleotide synthesis market 2018 - 2022
4.2 Application Segment Analysis 2018 - 2022
4.3 End-user Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Application
6.1 Market segments
6.2 Comparison by Application
6.3 PCR primers - Market size and forecast 2023-2028
6.4 PCR assays and panels - Market size and forecast 2023-2028
6.5 DNA microarrays - Market size and forecast 2023-2028
6.6 Fluorescence in situ hybridization - Market size and forecast 2023-2028
6.7 Sequencing and others - Market size and forecast 2023-2028
6.8 Market opportunity by Application
7 Market Segmentation by End-user
7.1 Market segments
7.2 Comparison by End-user
7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
7.4 Research and academic institutes - Market size and forecast 2023-2028
7.5 Diagnostic laboratories - Market size and forecast 2023-2028
7.6 Hospitals - Market size and forecast 2023-2028
7.7 Market opportunity by End-user
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 China - Market size and forecast 2023-2028
9.9 Germany - Market size and forecast 2023-2028
9.10 Canada - Market size and forecast 2023-2028
9.11 Japan - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Agilent Technologies Inc.
12.4 Ansa Biotechnologies
12.5 Biogen Inc.
12.6 Biotage AB
12.7 Danaher Corp.
12.8 General Electric Co.
12.9 Kaneka Corp.
12.10 LGC Science Group Holdings Ltd.
12.11 Merck KGaA
12.12 Mettler Toledo International Inc.
12.13 QIAGEN NV
12.14 Sarepta Therapeutics Inc.
12.15 Synbio Technologies
12.16 Syngene International Ltd.
12.17 Thermo Fisher Scientific Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global oligonucleotide synthesis market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on PCR primers - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on PCR primers - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on PCR primers - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on PCR primers - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on PCR assays and panels - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on PCR assays and panels - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on PCR assays and panels - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on PCR assays and panels - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on DNA microarrays - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on DNA microarrays - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on DNA microarrays - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on DNA microarrays - Year-over-year growth 2023-2028 (%)
Exhibits46: Chart on Fluorescence in situ hybridization - Market size and forecast 2023-2028 ($ million)
Exhibits47: Data Table on Fluorescence in situ hybridization - Market size and forecast 2023-2028 ($ million)
Exhibits48: Chart on Fluorescence in situ hybridization - Year-over-year growth 2023-2028 (%)
Exhibits49: Data Table on Fluorescence in situ hybridization - Year-over-year growth 2023-2028 (%)
Exhibits50: Chart on Sequencing and others - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Sequencing and others - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Sequencing and others - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Sequencing and others - Year-over-year growth 2023-2028 (%)
Exhibits54: Market opportunity by Application ($ million)
Exhibits55: Data Table on Market opportunity by Application ($ million)
Exhibits56: Chart on End-user - Market share 2023-2028 (%)
Exhibits57: Data Table on End-user - Market share 2023-2028 (%)
Exhibits58: Chart on Comparison by End-user
Exhibits59: Data Table on Comparison by End-user
Exhibits60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits64: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits69: Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits70: Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits72: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits73: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits74: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits75: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits76: Market opportunity by End-user ($ million)
Exhibits77: Data Table on Market opportunity by End-user ($ million)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits108: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits109: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits111: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits112: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits113: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits114: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits115: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits116: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits117: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits118: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ million)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits121: Impact of drivers and challenges in 2023 and 2028
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Agilent Technologies Inc. - Overview
Exhibits128: Agilent Technologies Inc. - Business segments
Exhibits129: Agilent Technologies Inc. - Key news
Exhibits130: Agilent Technologies Inc. - Key offerings
Exhibits131: Agilent Technologies Inc. - Segment focus
Exhibits132: Ansa Biotechnologies - Overview
Exhibits133: Ansa Biotechnologies - Product / Service
Exhibits134: Ansa Biotechnologies - Key news
Exhibits135: Ansa Biotechnologies - Key offerings
Exhibits136: Biogen Inc. - Overview
Exhibits137: Biogen Inc. - Product / Service
Exhibits138: Biogen Inc. - Key news
Exhibits139: Biogen Inc. - Key offerings
Exhibits140: Biotage AB - Overview
Exhibits141: Biotage AB - Product / Service
Exhibits142: Biotage AB - Key news
Exhibits143: Biotage AB - Key offerings
Exhibits144: Danaher Corp. - Overview
Exhibits145: Danaher Corp. - Business segments
Exhibits146: Danaher Corp. - Key news
Exhibits147: Danaher Corp. - Key offerings
Exhibits148: Danaher Corp. - Segment focus
Exhibits149: General Electric Co. - Overview
Exhibits150: General Electric Co. - Business segments
Exhibits151: General Electric Co. - Key news
Exhibits152: General Electric Co. - Key offerings
Exhibits153: General Electric Co. - Segment focus
Exhibits154: Kaneka Corp. - Overview
Exhibits155: Kaneka Corp. - Business segments
Exhibits156: Kaneka Corp. - Key offerings
Exhibits157: Kaneka Corp. - Segment focus
Exhibits158: LGC Science Group Holdings Ltd. - Overview
Exhibits159: LGC Science Group Holdings Ltd. - Product / Service
Exhibits160: LGC Science Group Holdings Ltd. - Key offerings
Exhibits161: Merck KGaA - Overview
Exhibits162: Merck KGaA - Business segments
Exhibits163: Merck KGaA - Key news
Exhibits164: Merck KGaA - Key offerings
Exhibits165: Merck KGaA - Segment focus
Exhibits166: Mettler Toledo International Inc. - Overview
Exhibits167: Mettler Toledo International Inc. - Business segments
Exhibits168: Mettler Toledo International Inc. - Key offerings
Exhibits169: Mettler Toledo International Inc. - Segment focus
Exhibits170: QIAGEN NV - Overview
Exhibits171: QIAGEN NV - Product / Service
Exhibits172: QIAGEN NV - Key offerings
Exhibits173: Sarepta Therapeutics Inc. - Overview
Exhibits174: Sarepta Therapeutics Inc. - Product / Service
Exhibits175: Sarepta Therapeutics Inc. - Key offerings
Exhibits176: Synbio Technologies - Overview
Exhibits177: Synbio Technologies - Product / Service
Exhibits178: Synbio Technologies - Key offerings
Exhibits179: Syngene International Ltd. - Overview
Exhibits180: Syngene International Ltd. - Product / Service
Exhibits181: Syngene International Ltd. - Key offerings
Exhibits182: Thermo Fisher Scientific Inc. - Overview
Exhibits183: Thermo Fisher Scientific Inc. - Business segments
Exhibits184: Thermo Fisher Scientific Inc. - Key news
Exhibits185: Thermo Fisher Scientific Inc. - Key offerings
Exhibits186: Thermo Fisher Scientific Inc. - Segment focus
Exhibits187: Inclusions checklist
Exhibits188: Exclusions checklist
Exhibits189: Currency conversion rates for US$
Exhibits190: Research methodology
Exhibits191: Validation techniques employed for market sizing
Exhibits192: Information sources
Exhibits193: List of abbreviations
